Differential regulation of myelin phagocytosis by macrophages/microglia, involvement of target myelin, Fc receptors and activation by intravenous immunoglobulins.
Macrophages/microglia are the key effector cells in myelin removal. Differences exist in the amount and time course of myelin uptake in the central (CNS) and peripheral nervous system (PNS), the basis of this difference, however, is not yet clarified. In the present experiments we studied the phagocytosis rate of CNS or PNS myelin by macrophages and microglia in vitro. Additionally, the effects of intravenous immunoglobulins (IVIg) on this process were investigated. In the PNS experiments, sciatic nerves were cocultured with peritoneal macrophages. Optic nerve fragments were used to characterize the myelin-removing properties of microglia. Cocultures with peritoneal macrophages aimed at investigating the differences in phagocytosis between resident microglia and added macrophages. The myelin phagocytosis in sciatic nerve fragments was higher than in optic nerves, indicating differences in the myelin uptake rate between peripheral macrophages and microglia. IVIg increased the phagocytosis of PNS myelin by macrophages, but not by microglia in optic nerves. The addition of peritoneal macrophages to optic nerve fragments did not lead to an increase in the phagocytosis of CNS myelin either. The IVIg induced phagocytosis of PNS myelin by peripheral macrophages was associated with an increased expression of macrophage Fc receptors measured by FACS. Blocking of Fc receptors by anti-Fc receptor antibody reduced the IVIg induced PNS myelin phagocytosis to basic levels, indicating that the induced but not the basic myelin uptake by macrophages is Fc receptor dependent. In contrast to peripheral macrophages, IVIg did not increase Fc receptor density on microglia. These data indicate that phagocytosis of PNS and CNS myelin by macrophages or microglia is differentially regulated. Local factors within the CNS or PNS may affect this process by modulating the surface receptor profile and activation state of the phagocytic cell or the structure of the myelin sheath.
Kuhlmann
Tanja
T
Department of Neuropathology, Charité, Humboldt-Universität, Berlin, Germany.
Wendling
Uwe
U
Nolte
Christiane
C
Zipp
Frauke
F
Maruschak
Brigitte
B
Stadelmann
Christine
C
Siebert
Heike
H
Brück
Wolfgang
W
D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D002478:Cells, Cultured; D002490:Central Nervous System / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D003711:Demyelinating Diseases / Q000276:immunology / Q000378:metabolism / Q000503:physiopathology; D005260:Female; D016756:Immunoglobulins, Intravenous / Q000276:immunology / Q000378:metabolism* / Q000494:pharmacology; D008264:Macrophages / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D017737:Macrophages, Peritoneal / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D017628:Microglia / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D009186:Myelin Sheath / Q000276:immunology / Q000378:metabolism*; D009416:Nerve Regeneration / Q000187:drug effects / Q000276:immunology; D009900:Optic Nerve / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D017933:Peripheral Nervous System / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D010587:Phagocytosis / Q000187:drug effects / Q000276:immunology*; D011961:Receptors, Fc / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism*; D012584:Sciatic Nerve / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D014855:Wallerian Degeneration / Q000276:immunology / Q000378:metabolism / Q000473:pathology
D000906:Antibodies; D016756:Immunoglobulins, Intravenous; D011961:Receptors, Fc